CardioSignal
The AI engine Fit Assessment
BetaThe company will be attending ViVE 2025 Event
Blurb
CardioSignal offers a digital cardiac biomarker for self-monitoring, remote care, and point-of-care diagnostics.
HQ Location
Turku (Finland)
Founded
2016
Employees
11 - 50
Total funding raised
$15.23M
Last Funding Event
Non-Equity Assistance, May 29, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of a digital cardiac biomarker designed for self-monitoring, remote care, and point-of-care diagnostics. The company's software provides features such as atrial fibrillation detection, vitals and heart physiology, measurement history, insights and news feed, measurement reminders and more, enabling clients to prevent strokes and heart attacks and improve outcomes.